Day One Biopharmaceuticals Ownership 2024 | Who Owns Day One Biopharmaceuticals Now?
Institutional Ownership
34.17%
Insider Ownership
19.60%
Retail Ownership
46.23%
Institutional Holders
79.00
Day One Biopharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9.08% | 1.43% | 7,871,721 | 61,869 | 0.79% | 108,472,315 | Jun 30, 2024 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 7.42% | 9.33% | 6,430,257 | - | - | 88,608,941 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.33% | 0.00% | 4,623,272 | -151,211 | -3.17% | 63,708,687 | Jun 30, 2024 |
| BLACKROCK INC. | 5.23% | 0.00% | 4,533,442 | -497,993 | -9.90% | 62,470,830 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 4.36% | 0.02% | 3,782,370 | -24,420 | -0.64% | 52,121,062 | Jun 30, 2024 |
| BRAIDWELL LP | 3.50% | 1.31% | 3,035,904 | 862,200 | 39.66% | 41,834,757 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.37% | 0.67% | 2,923,137 | 1,157,825 | 65.59% | 40,280,828 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 3.29% | 0.04% | 2,851,574 | 476,437 | 20.06% | 39,294,690 | Jun 30, 2024 |
| STATE STREET CORP | 3.26% | 0.00% | 2,826,820 | -68,063 | -2.35% | 38,953,580,000 | Jun 30, 2024 |
| FMR LLC | 3.07% | 0.00% | 2,661,444 | -1,742,897 | -39.57% | 36,674,695 | Jun 30, 2024 |
| ESTUARY CAPITAL MANAGEMENT LP | 3.04% | 11.71% | 2,635,270 | 1,024,133 | 63.57% | 36,314,021 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 2.95% | 0.14% | 2,558,563 | - | - | 35,256,998 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.71% | 0.00% | 2,350,880 | 51,116 | 2.22% | 32,396,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.20% | 0.00% | 1,903,108 | -234,383 | -10.97% | 26,224,828 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 2.12% | 0.01% | 1,839,269 | -193,115 | -9.50% | 25,363,520 | Jun 30, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 1.95% | 0.37% | 1,688,535 | 53,390 | 3.27% | 23,268,012 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.50% | 0.00% | 1,296,239 | -80,722 | -5.86% | 17,866,326 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.44% | 1.28% | 1,250,000 | 1,250,000 | 100.00% | 17,225,000 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 1.40% | 0.32% | 1,211,138 | -45,432 | -3.62% | 16,689,482 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.37% | 0.86% | 1,189,943 | - | - | 16,397,415 | Jun 30, 2024 |
Day One Biopharmaceuticals's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 9.08% of the company's total share outstanding, currently valued at $108.47M. The top 10 institutional shareholders own together 47.92% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ESTUARY CAPITAL MANAGEMENT LP | 3.04% | 11.71% | 2,635,270 | 1,024,133 | 63.57% | 36,314,021 | Jun 30, 2024 |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 7.42% | 9.33% | 6,430,257 | - | - | 88,608,941 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.62% | 4.40% | 536,095 | 536,095 | 100.00% | 7,387,389 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.77% | 2.19% | 666,463 | - | - | 9,183,860 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.05% | 1.68% | 908,822 | 217,010 | 31.37% | 12,523,567 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 9.08% | 1.43% | 7,871,721 | 61,869 | 0.79% | 108,472,315 | Jun 30, 2024 |
| BRAIDWELL LP | 3.50% | 1.31% | 3,035,904 | 862,200 | 39.66% | 41,834,757 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.44% | 1.28% | 1,250,000 | 1,250,000 | 100.00% | 17,225,000 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 1.37% | 0.86% | 1,189,943 | - | - | 16,397,415 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.37% | 0.67% | 2,923,137 | 1,157,825 | 65.59% | 40,280,828 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.40% | 0.65% | 347,627 | -145,000 | -29.43% | 4,790,300 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.23% | 0.57% | 196,425 | - | - | 2,706,737 | Jun 30, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 1.95% | 0.37% | 1,688,535 | 53,390 | 3.27% | 23,268,012 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.23% | 0.36% | 200,000 | 200,000 | 100.00% | 2,756,000 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 1.40% | 0.32% | 1,211,138 | -45,432 | -3.62% | 16,689,482 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 0.46% | 0.27% | 396,644 | 41,393 | 11.65% | 5,465,754 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.03% | 0.17% | 25,491 | 19,413 | 319.40% | 351,266 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 2.95% | 0.14% | 2,558,563 | - | - | 35,256,998 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.02% | 0.11% | 15,023 | -3,773 | -20.07% | 207,016 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.81% | 0.09% | 706,446 | -12,565 | -1.75% | 9,734,826 | Jun 30, 2024 |
The largest Day One Biopharmaceuticals shareholder by % of total assets is ESTUARY CAPITAL MANAGEMENT LP. The company owns 2.64M shares of Day One Biopharmaceuticals (DAWN), representing 11.71% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 1.44% | 1.28% | 1,250,000 | 1,250,000 | 100.00% | 17,225,000 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.37% | 0.67% | 2,923,137 | 1,157,825 | 65.59% | 40,280,828 | Jun 30, 2024 |
| ESTUARY CAPITAL MANAGEMENT LP | 3.04% | 11.71% | 2,635,270 | 1,024,133 | 63.57% | 36,314,021 | Jun 30, 2024 |
| BRAIDWELL LP | 3.50% | 1.31% | 3,035,904 | 862,200 | 39.66% | 41,834,757 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.62% | 4.40% | 536,095 | 536,095 | 100.00% | 7,387,389 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 3.29% | 0.04% | 2,851,574 | 476,437 | 20.06% | 39,294,690 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.54% | 0.02% | 470,247 | 470,247 | 100.00% | 6,480,004 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.64% | 0.04% | 555,108 | 445,108 | 404.64% | 7,649,388 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.82% | 0.09% | 707,531 | 434,993 | 159.61% | 9,749,777 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.35% | 0.01% | 299,206 | 278,794 | 1365.83% | 4,123,059 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 1.05% | 1.68% | 908,822 | 217,010 | 31.37% | 12,523,567 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.23% | 0.36% | 200,000 | 200,000 | 100.00% | 2,756,000 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.22% | 0.00% | 186,484 | 186,484 | 100.00% | 2,569,750 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.20% | 0.05% | 173,738 | 173,738 | 100.00% | 2,394,110 | Jun 30, 2024 |
| NORGES BANK | 0.20% | 0.00% | 169,000 | 169,000 | 100.00% | 2,328,820 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.19% | 0.00% | 167,765 | 138,757 | 478.34% | 2,311,802 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.11% | 0.01% | 98,624 | 98,624 | 100.00% | 1,359,000 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.13% | 0.00% | 113,020 | 94,703 | 517.02% | 1,557,415 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.08% | 0.00% | 72,140 | 72,140 | 100.00% | 994,089 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 9.08% | 1.43% | 7,871,721 | 61,869 | 0.79% | 108,472,315 | Jun 30, 2024 |
As of Jun 30 2024, Day One Biopharmaceuticals's largest institutional buyer is VESTAL POINT CAPITAL, LP. The company purchased 1.25M stocks of DAWN, valued at $17.23M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 3.07% | 0.00% | 2,661,444 | -1,742,897 | -39.57% | 36,674,695 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | - | - | - | -1,318,207 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 5.23% | 0.00% | 4,533,442 | -497,993 | -9.90% | 62,470,830 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -361,767 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -349,679 | -100.00% | - | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | - | - | - | -270,664 | -100.00% | - | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 1.08% | 0.08% | 935,000 | -250,000 | -21.10% | 12,884,300 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.20% | 0.00% | 1,903,108 | -234,383 | -10.97% | 26,224,828 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 2.12% | 0.01% | 1,839,269 | -193,115 | -9.50% | 25,363,520 | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | - | - | - | -175,018 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -159,000 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.33% | 0.00% | 4,623,272 | -151,211 | -3.17% | 63,708,687 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.03% | 0.00% | 22,592 | -146,930 | -86.67% | 311,318 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.40% | 0.65% | 347,627 | -145,000 | -29.43% | 4,790,300 | Jun 30, 2024 |
| UBS GROUP AG | 0.08% | 0.00% | 70,083 | -93,935 | -57.27% | 965,743 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.02% | 0.00% | 888,117 | -93,455 | -9.52% | 12,238,409 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.02% | 0.00% | 14,873 | -82,748 | -84.76% | 205,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.50% | 0.00% | 1,296,239 | -80,722 | -5.86% | 17,866,326 | Jun 30, 2024 |
| STATE STREET CORP | 3.26% | 0.00% | 2,826,820 | -68,063 | -2.35% | 38,953,580,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.19% | 0.00% | 167,246 | -65,304 | -28.08% | 2,304,649 | Jun 30, 2024 |
As of Jun 30 2024, Day One Biopharmaceuticals's biggest institutional seller is FMR LLC. The company sold -1.74M shares of DAWN, valued at $36.67M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | 1.44% | 1.28% | 1,250,000 | 1,250,000 | 100.00% | 17,225,000 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.62% | 4.40% | 536,095 | 536,095 | 100.00% | 7,387,389 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.23% | 0.36% | 200,000 | 200,000 | 100.00% | 2,756,000 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.20% | 0.05% | 173,738 | 173,738 | 100.00% | 2,394,110 | Jun 30, 2024 |
| NORGES BANK | 0.20% | 0.00% | 169,000 | 169,000 | 100.00% | 2,328,820 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.08% | 0.00% | 72,140 | 72,140 | 100.00% | 994,089 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.05% | 0.00% | 45,652 | 45,652 | 100.00% | 629,085 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 38,174 | 38,174 | 100.00% | 526,319 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.04% | 0.09% | 35,100 | 35,100 | 100.00% | 483,678 | Jun 30, 2024 |
| TORNO CAPITAL, LLC | 0.03% | 0.02% | 30,000 | 30,000 | 100.00% | 413,400 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 27,924 | 27,924 | 100.00% | 384,793 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.03% | 0.01% | 25,000 | 25,000 | 100.00% | 344,500 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.03% | 0.00% | 23,653 | 23,653 | 100.00% | 325,938 | Jun 30, 2024 |
| STEEL PEAK WEALTH MANAGEMENT LLC | 0.02% | 0.01% | 15,850 | 15,850 | 100.00% | 218,413 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.02% | 0.04% | 14,008 | 14,008 | 100.00% | 193,030 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.02% | 0.01% | 13,822 | 13,822 | 100.00% | 190,467 | Jun 30, 2024 |
| TORNO CAPITAL, LLC | 0.01% | 0.01% | 13,037 | 13,037 | 100.00% | 179,650 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.01% | 0.00% | 11,658 | 11,658 | 100.00% | 162,513 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.01% | 0.00% | 10,366 | 10,366 | 100.00% | 142,843 | Jun 30, 2024 |
| MARINER, LLC | 0.01% | 0.00% | 10,027 | 10,027 | 100.00% | 138,172 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 137,800 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.01% | 0.00% | 8,992 | 8,992 | 100.00% | 123,909 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.00% | 0.00% | 1,900 | 1,900 | 100.00% | 26,182 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,751 | 1,751 | 100.00% | 24,128 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 168 | 168 | 100.00% | 2,315 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 71 | 71 | 100.00% | 1,000 | Jun 30, 2024 |
| GLOBAL TRUST ASSET MANAGEMENT, LLC | 0.00% | 0.00% | 50 | 50 | 100.00% | 689 | Jun 30, 2024 |
| C M BIDWELL & ASSOCIATES LTD | - | 0.00% | 28 | 28 | 100.00% | 386 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | - | - | 19 | 19 | 100.00% | 262 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | - | - | 8 | 8 | 100.00% | 111 | Jun 30, 2024 |
Day One Biopharmaceuticals's largest new institutional shareholder by number of shares is VESTAL POINT CAPITAL, LP, purchased 1.25M shares, valued at $17.23M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FIRST TURN MANAGEMENT, LLC | - | - | - | -1,318,207 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -361,767 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -349,679 | -100.00% | - | Jun 30, 2024 |
| PROPEL BIO MANAGEMENT, LLC | - | - | - | -270,664 | -100.00% | - | Jun 30, 2024 |
| SIMPLIFY ASSET MANAGEMENT INC. | - | - | - | -175,018 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -159,000 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -53,152 | -100.00% | - | Jun 30, 2024 |
| SUMMIT ROCK ADVISORS, LP | - | - | - | -51,502 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -32,142 | -100.00% | - | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -32,029 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -30,877 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -24,042 | -100.00% | - | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | - | - | - | -19,419 | -100.00% | - | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | - | - | - | -18,560 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -17,977 | -100.00% | - | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | - | - | - | -13,935 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -13,374 | -100.00% | - | Jun 30, 2024 |
| QUARRY LP | - | - | - | -6,400 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,691 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -582 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -12 | -100.00% | - | Jun 30, 2024 |
Day One Biopharmaceuticals's largest sold out institutional shareholder by shares sold is FIRST TURN MANAGEMENT, LLC, sold -1.32M shares, valued at -, as of undefined.
Day One Biopharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Tema ETF Trust | 0.92% | 40,958 | 28,418 | 226.62% | Feb 29, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.29% | 1,430,839 | 171,392 | 13.61% | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.25% | 2,081,203 | - | - | Jan 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.19% | 22,400 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.09% | 110,000 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.08% | 41,661 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.08% | 199,995 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.07% | 237,820 | -17,215 | -6.75% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.05% | 406,669 | - | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.04% | 1,013,393 | -54,551 | -5.11% | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.03% | 287,384 | - | - | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.02% | 93,175 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 111,530 | -3,070 | -2.68% | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.02% | 57,729 | -218,157 | -79.08% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,043 | -588 | -6.11% | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 46,502 | 744 | 1.63% | Feb 29, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 91,858 | 33,436 | 57.23% | Mar 28, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 901,833 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,092,371 | -885,225 | -17.78% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 607,633 | 159,900 | 35.71% | Feb 29, 2024 |
| ALPS ETF Trust | 0.01% | 64,439 | 3,008 | 4.90% | Feb 29, 2024 |
| AMG FUNDS | 0.00% | 137,900 | 2,000 | 1.47% | Mar 28, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 10,425 | -3,689 | -26.14% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 170,155 | -2,173 | -1.26% | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 5,754 | -1,585 | -21.60% | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 28,524 | - | - | Jan 31, 2024 |
| Simplify Exchange Traded Funds | 0.00% | 175,018 | - | - | Mar 28, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 731 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 553,158 | -702 | -0.13% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 6,279 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 3,030 | -11,100 | -78.56% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 226,929 | 40,808 | 21.93% | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 24,990 | 2,207 | 9.69% | Jan 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 400,350 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 37,911 | -2,949 | -7.22% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 3,996 | 2,999 | 300.80% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 21,839 | 5,761 | 35.83% | Mar 31, 2024 |
| ProFunds | 0.00% | 10,290 | -3,485 | -25.30% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 158,900 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 9,741 | -800 | -7.59% | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 48,037 | -8,571 | -15.14% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 73,528 | 40,755 | 124.36% | Feb 29, 2024 |
| Global X Funds | 0.00% | 33,901 | - | - | Jan 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 7,200 | 7,200 | - | Mar 28, 2024 |
| Dimensional ETF Trust | 0.00% | 321,205 | 53,020 | 19.77% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 162,524 | 14,871 | 10.07% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 20,813 | -4,673 | -18.34% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,961 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 5,600 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 11,849 | 1,898 | 19.07% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 290,969 | 10,047 | 3.58% | Feb 29, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 4,475 | 4,475 | - | Mar 28, 2024 |
| BlackRock ETF Trust | 0.00% | 404 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 376,387 | 242,729 | 181.60% | Jan 31, 2024 |
| Dunham Funds | 0.00% | 24,996 | 24,996 | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 21,400 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 3,403 | 453 | 15.36% | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 337,665 | -30,240 | -8.22% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 722 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 34,181 | 124 | 0.36% | Mar 28, 2024 |
| iSHARES TRUST | 0.00% | 2,733,183 | -159,368 | -5.51% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 175,282 | 5,020 | 2.95% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 19,180 | 1,837 | 10.59% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 287,075 | 35,552 | 14.13% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 569 | - | - | Dec 31, 2023 |
| Trust for Advised Portfolios | 0.00% | 2,567 | - | - | Dec 31, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 8,852 | 4,744 | 115.48% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 24,044 | -97 | -0.40% | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 33,673 | 3,055 | 9.98% | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 9,523 | -352 | -3.56% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 282 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 1,900 | -400 | -17.39% | Mar 28, 2024 |
| Brighthouse Funds Trust II | 0.00% | 57,643 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 15,684 | 2,040 | 14.95% | Feb 29, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 977 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 6,270 | - | - | Feb 29, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 10,818 | 10,818 | - | Jan 31, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 5,663 | 5,663 | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 138,136 | -217,210 | -61.13% | Jan 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 1,609,839 | -499,110 | -23.67% | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,214 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 84,613 | 2,643 | 3.22% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 7,568 | 1,070 | 16.47% | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 37 | - | - | Dec 31, 2023 |
| Pacer Funds Trust | 0.00% | 1,292 | -894 | -40.90% | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 10,372 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,325 | - | - | Feb 29, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 95,000 | - | - | Mar 31, 2024 |
| TRANSAMERICA SERIES TRUST | 0.00% | 20,533 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 122 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 7,098 | -29 | -0.41% | Jan 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 42,800 | 42,800 | - | Mar 28, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 25,143 | -11,485 | -31.36% | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 11,974 | - | - | Mar 31, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 12,327 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 32,766 | 3,797 | 13.11% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 2,328 | 804 | 52.76% | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 21,945 | 921 | 4.38% | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 14,368 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 4,857 | - | - | Dec 31, 2023 |
Day One Biopharmaceuticals's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 40.96K shares, compromising 0.92% of its total assets.
Day One Biopharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 79 | -46.62% |
| 31 Mar, 24 | 148 | 8.03% |
| 31 Dec, 23 | 137 | 7.87% |
| 30 Sep, 23 | 127 | -9.93% |
| 30 Jun, 23 | 141 | 11.90% |
| 31 Mar, 23 | 126 | 14.55% |
| 31 Dec, 22 | 110 | 19.57% |
| 30 Sep, 22 | 92 | 1.10% |
| 30 Jun, 22 | 91 | 37.88% |
| 31 Mar, 22 | 66 | 15.79% |
| 31 Dec, 21 | 57 | 26.67% |
| 30 Sep, 21 | 45 | 40.63% |
| 30 Jun, 21 | 32 | - |
As of 30 Jun 24, 79 institutions are holding Day One Biopharmaceuticals's shares, representing a decrease of -46.62% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 29,622,631 | -59.09% |
| 31 Mar, 24 | 72,408,321 | -5.34% |
| 31 Dec, 23 | 76,496,552 | -1.07% |
| 30 Sep, 23 | 77,325,767 | -1.72% |
| 30 Jun, 23 | 78,677,125 | 28.65% |
| 31 Mar, 23 | 61,156,474 | 1.53% |
| 31 Dec, 22 | 60,234,362 | -0.87% |
| 30 Sep, 22 | 60,764,802 | 2.33% |
| 30 Jun, 22 | 59,382,173 | 37.13% |
| 31 Mar, 22 | 43,302,484 | 4.40% |
| 31 Dec, 21 | 41,477,324 | 117.20% |
| 30 Sep, 21 | 19,096,040 | 7.74% |
| 30 Jun, 21 | 17,724,839 | - |
Day One Biopharmaceuticals (DAWN) has 29.62M shares outstanding as of 30 Jun 24, down -59.09% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 34.17% | 0.41% |
| 31 Mar, 24 | 90.77% | 1.15% |
| 31 Dec, 23 | 89.00% | 0.84% |
| 30 Sep, 23 | 103.15% | 0.86% |
| 30 Jun, 23 | 109.31% | 1.51% |
| 31 Mar, 23 | 84.97% | 1.00% |
| 31 Dec, 22 | 92.01% | 1.26% |
| 30 Sep, 22 | 85.57% | 0.90% |
| 30 Jun, 22 | 97.73% | 1.78% |
| 31 Mar, 22 | 74.17% | 0.59% |
| 31 Dec, 21 | 112.22% | 4.20% |
| 30 Sep, 21 | 51.67% | 0.84% |
| 30 Jun, 21 | 78.21% | - |
As of 30 Jun 24, Day One Biopharmaceuticals is held by 34.17% institutional shareholders, representing a 0.41% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 34 | -53.42% |
| 31 Mar, 24 | 73 | -2.67% |
| 31 Dec, 23 | 75 | 10.29% |
| 30 Sep, 23 | 68 | -30.61% |
| 30 Jun, 23 | 98 | 42.03% |
| 31 Mar, 23 | 69 | 9.52% |
| 31 Dec, 22 | 63 | 10.53% |
| 30 Sep, 22 | 57 | -9.52% |
| 30 Jun, 22 | 63 | 61.54% |
| 31 Mar, 22 | 39 | -7.14% |
| 31 Dec, 21 | 42 | 31.25% |
| 30 Sep, 21 | 32 | - |
| 30 Jun, 21 | 32 | - |
34 institutional shareholders have increased their position in DAWN stock as of 30 Jun 24 compared to 73 in the previous quarter (a -53.42% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 27 | -37.21% |
| 31 Mar, 24 | 43 | 26.47% |
| 31 Dec, 23 | 34 | 3.03% |
| 30 Sep, 23 | 33 | 43.48% |
| 30 Jun, 23 | 23 | -20.69% |
| 31 Mar, 23 | 29 | 20.83% |
| 31 Dec, 22 | 24 | 33.33% |
| 30 Sep, 22 | 18 | 20.00% |
| 30 Jun, 22 | 15 | 25.00% |
| 31 Mar, 22 | 12 | 140.00% |
| 31 Dec, 21 | 5 | -28.57% |
| 30 Sep, 21 | 7 | - |
| 30 Jun, 21 | - | - |
27 institutional shareholders have reduced their position in DAWN stock as of 30 Jun 24 compared to 43 in the previous quarter (a -37.21% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 79 | -46.62% | 29,622,631 | -59.09% | 34.17% | 0.41% | 34 | -53.42% | 27 | -37.21% |
| 31 Mar, 24 | 148 | 8.03% | 72,408,321 | -5.34% | 90.77% | 1.15% | 73 | -2.67% | 43 | 26.47% |
| 31 Dec, 23 | 137 | 7.87% | 76,496,552 | -1.07% | 89.00% | 0.84% | 75 | 10.29% | 34 | 3.03% |
| 30 Sep, 23 | 127 | -9.93% | 77,325,767 | -1.72% | 103.15% | 0.86% | 68 | -30.61% | 33 | 43.48% |
| 30 Jun, 23 | 141 | 11.90% | 78,677,125 | 28.65% | 109.31% | 1.51% | 98 | 42.03% | 23 | -20.69% |
| 31 Mar, 23 | 126 | 14.55% | 61,156,474 | 1.53% | 84.97% | 1.00% | 69 | 9.52% | 29 | 20.83% |
| 31 Dec, 22 | 110 | 19.57% | 60,234,362 | -0.87% | 92.01% | 1.26% | 63 | 10.53% | 24 | 33.33% |
| 30 Sep, 22 | 92 | 1.10% | 60,764,802 | 2.33% | 85.57% | 0.90% | 57 | -9.52% | 18 | 20.00% |
| 30 Jun, 22 | 91 | 37.88% | 59,382,173 | 37.13% | 97.73% | 1.78% | 63 | 61.54% | 15 | 25.00% |
| 31 Mar, 22 | 66 | 15.79% | 43,302,484 | 4.40% | 74.17% | 0.59% | 39 | -7.14% | 12 | 140.00% |
| 31 Dec, 21 | 57 | 26.67% | 41,477,324 | 117.20% | 112.22% | 4.20% | 42 | 31.25% | 5 | -28.57% |
| 30 Sep, 21 | 45 | 40.63% | 19,096,040 | 7.74% | 51.67% | 0.84% | 32 | - | 7 | - |
| 30 Jun, 21 | 32 | - | 17,724,839 | - | 78.21% | - | 32 | - | - | - |
Day One Biopharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Day One Biopharmaceuticals's stock was made by Blackman Samuel C. on Jul 17 2024, selling 20,000 shares at $16.01 per share (valued at $320.23K). The last insider buy of DAWN was made by AI Day1 LLC on Aug 05 2024, buying 827,586 shares at - per share (worth $82.76).
Day One Biopharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 4 | 5 | 80.00% |
| Q2 2024 | 20 | 26 | 76.92% |
| Q1 2024 | 22 | 19 | 115.79% |
| Q4 2023 | 11 | 16 | 68.75% |
| Q3 2023 | 10 | 14 | 71.43% |
| Q2 2023 | 14 | 10 | 140.00% |
| Q1 2023 | 12 | 22 | 54.55% |
| Q4 2022 | 3 | 29 | 10.34% |
| Q3 2022 | 3 | 62 | 4.84% |
| Q2 2022 | 16 | 1 | 1600.00% |
| Q1 2022 | 9 | 2 | 450.00% |
| Q4 2021 | 2 | 12 | 16.67% |
| Q3 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 17 | 31 | 54.84% |
| Q1 2021 | 2 | - | - |
4 total buy trades, and 5 total sell trades (buy/sell ratio of 0.80%) were made by Day One Biopharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | - | 14 | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | 3 | 4 | 75.00% |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 1 | 4 | 25.00% |
| Q1 2023 | - | 16 | - |
| Q4 2022 | - | 25 | - |
| Q3 2022 | - | 55 | - |
| Q2 2022 | 5 | 1 | 500.00% |
| Q1 2022 | 3 | 2 | 150.00% |
| Q4 2021 | - | 8 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 6 | - | - |
| Q1 2021 | 1 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Day One Biopharmaceuticals's stocks.
DAWN Ownership FAQ
Who Owns Day One Biopharmaceuticals?
Day One Biopharmaceuticals is owned by institutional shareholders (34.17%), insiders (19.60%), and public (46.23%). The largest institutional shareholder of Day One Biopharmaceuticals is RA CAPITAL MANAGEMENT, L.P. (9.08% of total shares) and the top mutual fund owner is Tema ETF Trust (0.92% of total shares).
Who are the major institutional shareholders of Day One Biopharmaceuticals?
Day One Biopharmaceuticals's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, VANGUARD GROUP INC, BLACKROCK INC., and FRANKLIN RESOURCES INC. The top five shareholders own together 31.43% of the company's share outstanding.
How many Day One Biopharmaceuticals shareholders are there?
As of Jun 2024, there are 79 institutional shareholders of Day One Biopharmaceuticals.
What percentage of Day One Biopharmaceuticals is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 7.87M shares of Day One Biopharmaceuticals, representing 9.08% of the company's total shares outstanding, valued at $108.47M (as of Jun 2024).
What percentage of Day One Biopharmaceuticals is owned by ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC?
As of Jun 2024, ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC holds 6.43M shares of Day One Biopharmaceuticals (DAWN), compromising 7.42% of the company, valued at $88.61M.
What percentage of Day One Biopharmaceuticals is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Day One Biopharmaceuticals. The company owns 4.62M of the company's shares outstanding (worth $63.71M).